Market Tracker

01/20 5:16pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

2.60
Delayed Data
As of Jan 20
 +0.05 / +1.96%
Today’s Change
2.35
Today|||52-Week Range
5.48
+6.12%
Year-to-Date

Today’s Trading

Previous close2.55
Today’s open2.60
Day’s range2.50 - 2.65
Volume202,566
Average volume (3 months)284,934
Market cap$142.6M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-177.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.26

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp+0.10+1.87%
XENEXenon Pharmaceutical...-0.10-1.20%
SMMTSummit Therapeutics ...+0.19+1.73%
VTLVital Therapies Inc0.000.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts